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Background: The cardiovascular (CV) and metabolic health benefits or risks associated with consumption of
multi-ingredient performance supplements (MIPS) in conjunction with periodized resistance training (RT) in
resistance-trained men are unknown. This population is a major target audience for performance supplements,
and therefore, the purpose of this study was to investigate the combined effect of RT and commercially available
pre- and post-exercise performance supplements on CV health and body fat in resistance-trained men.
Methods: Twenty-four resistance-trained men completed six weeks (three times/week) of periodized RT while
either ingesting SHOT 15-min pre-exercise and SYN immediately post-exercise (multi-ingredient performance
supplement group: MIPS) or an isocaloric maltodextrin placebo 15-min pre-exercise and immediately post-exercise
(Placebo group). Before and after six weeks of RT and supplementation, resting heart rate (HR), blood pressure (BP),
total body fat, android fat, gynoid fat, fat-free mass (FFM) and fasting blood measures of glucose, lipids, nitrate/nitrite
(NOx), cortisol and high sensitivity C-reactive protein (hs-CRP) were measured. Statistical analysis was conducted using
a one-way ANOVA for baseline differences and a 2 × 2 (group × time) repeated measures ANOVA and Tukey post-hoc
tests where appropriate. Significance was set at p < 0.05.
Results: There was no group × time interaction for HR, BP, blood glucose, lipids, NOx, hs-CRP, cortisol concentrations or
body fat. However, there was a time effect where significant decreases in body fat (mean ± SD; MIPS: -1.2 ± 1.2%;
Placebo: -0.9 ± 1.1%), android fat (MIPS: -1.8 ± 2.1%; Placebo: -1.6 ± 2.0%), and gynoid fat (MIPS: -1.3 ± 1.6%;
Placebo: -1.0 ± 1.4%) for both groups were observed. FFM increased in both groups, and a group × time interaction
was observed with MIPS increasing significantly more than the Placebo group (4.2% vs. 1.9%).
Conclusions: Six weeks of MIPS ingestion and periodized RT does not alter CV health parameters or blood indices of
health or body fat more than a Placebo treatment in healthy, resistance-trained men. However, MIPS significantly
increased FFM more than Placebo.
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Nutritional supplements intended for consumption before
and after resistance training (RT) to improve performance
are extremely popular among young men and athletes
[1,2]. Given that RT has been shown to increase muscle
fiber size and strength in men and women [3] with a
concomitant increase in lipolysis and fat oxidation [4], it is
not surprising that performance supplements are consumed
in conjunction with RT in an attempt to improve body
composition and athletic performance. The components of
these popular multi-ingredient performance supplements
(MIPS; e.g. whey protein, casein protein, branched-chain
amino acids (BCAA’s), creatine, β-alanine, caffeine, and
L-arginine) have been studied individually for their
ergogenic effects [5-8]; however, the health and safety
outcomes of these supplements are not well known when
consumed in combination in a well-trained population.
Caffeine alone has been shown to increase resting blood
pressure (BP) acutely [9], and potentially chronically [10].
Systolic blood pressure (SBP) and heart rate (HR) have
also been shown to increase during RT with acute caffeine
supplementation in resistance-trained men [11]. However,
recent studies evaluating supplements that contain
caffeine do not report measures of BP or HR [12-14].
Multiple side effects have been demonstrated with the
use of MIPS. Shelmadine et al. [12] investigated eighteen
untrained men following 28 days of RT (4×/week) when
consuming NO-Shotgun® (Vital Pharmaceuticals, Davie, FL)
containing a blend of protein, BCAA’s, creatine, β-alanine,
caffeine, and L-arginine consumed 30 minutes before
RT compared to an isocaloric placebo (maltodextrin) and
found side effects including dizziness, nausea, headache,
and shortness of breath in 44% (n = 4 of 9) of this group’s
participants. However, 44% (n = 4 of 9) of participants
taking the placebo also experienced side effects of nausea
and shortness of breath. Interestingly, the authors did not
report BP or HR data, which may be important given
these side effects and media reports portraying these
pre- and post-RT products as dangerous. However, fasting
blood lipid profile and glucose were not altered in either
group. Significant increases were reported in fat-free
mass (FFM) with no significant changes in fat mass.
This improvement in body composition likely overrides
the potential negative consequences to using MIPS
supplements for the young athletes targeted by such
products [1,2] as anecdotal evidence suggests that young
weight training men are most concerned with adding
muscle mass.
In a follow-up study, Spillane et al. [13] investigated
untrained men and provided NO-Shotgun® (Vital
Pharmaceuticals, Davie, FL) pre-RT and added consumption
NO-Synthesize®, (Vital Pharmaceuticals, Davie, FL)
immediately post-RT and on all non-RT days. The authors
reported similar side effects for these untrained participantsincluding nausea, rapid HR, and shortness of breath
regardless of being in the MIPS or placebo groups [13].
Again, BP and HR data were not reported but significant
(p = 0.023) increases in FFM were found in the supplement
group when compared to the placebo group after 28 days
(mean ± SD; Supplement: Day 0, 57.8 ± 6.4 kg vs. Day 28,
59.9 ± 7.6 kg; placebo: Day 0, 56.4 ± 10.3 kg vs. Day 28,
57.0 ± 9.9 kg). In addition, whole blood and serum clinical
chemistry markers, regardless of group, remained in the
normal ranges in this study [13]. The health implications
of MIPS use in trained men, however, deserve further
investigation.
Therefore, the purpose of the present study was to
evaluate the effects of six weeks of pre- and post-RT MIPS
consumption with periodized RT on cardiovascular (CV)
and metabolic health and body fat in resistance-trained
men. We hypothesized that the inclusion of a pre- and
post-RT MIPS with resistance-trained participants would
not alter CV markers of health, but would improve cortisol,
mood state, and body fat more than a placebo supplement.
Methods
Participants
Twenty-nine healthy, resistance trained (≥3× per week;
training for ≥12 months) men (mean ± SD; age, 24.0 ± 2.3
years; height, 180.5 ± 5.8 cm; body mass, 83.7 ± 0.5 kg;
body mass index, BMI, 25.5 ± 2.2 kg ∙ m2) began this study.
However, five (MIPS: n = 1; Placebo: n = 4) withdrew over
the course of the six-week protocol (three for personal
reasons, one was found to be a smoker, and one did not
follow the RT protocol). Participants were non-smokers
and had no known existing diseases, musculoskeletal
disorders or injuries, uncontrolled hypertension (BP > 140/
90 mmHg), uncontrolled cholesterol/blood lipid levels, use
of cholesterol medication, or dairy allergies as assessed by
a medical history questionnaire. Those reporting anabolic
steroid use on the medical history form were excluded.
Use of other performance supplements (e.g. caffeine,
β-alanine, and creatine monohydrate) required a four-
week washout period [15] prior to participation (excluding
multivitamins). Participants were instructed not to take
any supplement, other than the provided pre- and post-RT
supplements, for the duration of the study. All procedures
involving human subjects were approved by The Florida
State University Human Subjects Institutional Review
Board in accordance with the Helsinki Declaration. Written
informed consent was obtained prior to participation.
Study design and supplementation protocol
Participants were randomly assigned to one of two groups
in this placebo-controlled, double blind, six-week protocol
after being stratified by isometric maximal voluntary
contraction strength (dominant quadriceps) to FFM ratio.
Participants in the MIPS group consumed 21 g of NO-
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0 g carbohydrates, 0 g fat, caffeine ~190 mg; containing a
proprietary blend of whey protein, BCAA’s, creatine,
β-alanine, and L-arginine (Vital Pharmaceuticals, Davie, FL)
15 minutes before RT and 21 g of NO-Synthesize® (SYN)
which contained ~80 kcals, 20 g protein, 0 g carbohy-
drate, 0 g fat; containing a proprietary blend of whey pro-
tein, BCAA’s, creatine, β-alanine, and L-arginine (Vital
Pharmaceuticals, Davie, FL) immediately after RT. Partici-
pants in the Placebo group consumed 21 g of an isocalo-
ric, flavor-matched maltodextrin placebo 15 minutes
before RT and 21 g immediately post-RT. All supplements
were distributed in identical single-serving Ziploc® bags
before and after each workout and research personnel
watched as each participant consumed the supplement on
all training days. For all non-training days, participants
were given single-servings of the supplement in Ziploc®
bags to take home and consume. In the morning for
non-training days, MIPS consumed 21 g/day of SYN
and the Placebo group consumed 21 g/day of Placebo.
These empty bags were collected and participants were
asked to verbally verify supplement compliance on each
workout day (our acceptable compliance margin was set
to >80% to be included in the data analysis).
Laboratory testing
Laboratory testing took place only before and after the
six-week intervention. Profile of mood state [16], HR,
BP, body composition, and blood measures took place
following a 10-hour fast and a 24-hour restriction of
physical activity, caffeine, and alcohol intake at baseline
and after six weeks of RT and supplement intervention.
Six-week testing (post) took place 48 hours after conclusion
of RT to avoid any residual impact of the last training
session on dependent variables including blood markers
of inflammation (hs-CRP) and catabolism (cortisol) which
may be elevated following an acute bout of RT, but not as
a result of RT over the entire study period.
Profile of mood states (POMS)
POMS [16] scores were measured upon arriving to the
laboratory and were used to measure mood before and
after the six-week intervention. These scores are compiled
based on responses to 65 mood descriptors and divided
into six categories describing tension, depression, anger,
vigor, fatigue, and confusion. In addition, total mood score
was calculated. Participants were asked to consider their
mood over the previous seven days in their responses.
Heart rate and blood pressure
Participants rested in a seated position for five minutes
after completing the profile of mood states questionnaire.
Afterwards, SBP and DPB were measured twice by the
same investigator at the same time of day and on the sameday and averaged using a manual sphygmomanometer
(American Diagnostic Corp., Hauppauge, NY) and stetho-
scope. HR was measured manually at the radial artery for
60 seconds.
Anthropometrics and body composition
Height and body mass were measured using a wall-mount
stadiometer and electronic scale, respectively (SECA,
Birmingham, UK). Total fat mass (FM), FFM, and regional
(android and gynoid mass) body composition was deter-
mined by dual energy x-ray absorptiometry (DXA; model
DPX-IQ; GE Medical Systems; Madison, WI) with partici-
pants in the supine position as previously described [17].
Coefficient of variation for body composition analysis
using DXA in our laboratory for FFM and FM was 1.9%
and 1.5% respectively, based on three repeated measures
of 10 physically active young men. The quality analysis for
the densitometer was conducted on a daily basis using a
standard aluminum spine block (phantom) provided by the
manufacturer. Measurements of the phantom were within
the manufacturer’s precision standard with a coefficient of
variation <0.5%.
Cardiovascular and metabolic biomarkers
Venous blood samples (10 ml) were obtained before
and after six weeks of RT and supplementation with
MIPS or Placebo. Blood samples were collected in the
morning on both laboratory visits as close to the same
time as possible into either no preservative (serum) or
EDTA-coated (plasma) vacutainer tubes (Becton, Dickinson
& Company, Franklin Lakes, NJ) and centrifuged (IEC
CL3R Multispeed Centrifuge, Thermo Electron Corpor-
ation, Needham Heights, MA) for 15 minutes at 3500
rpm at 4°C. Plasma and serum were then separated and
subsequently stored at −80°C in 300 μL aliquots until
analyzed. Blood was analyzed for total cholesterol (TC),
high-density lipoproteins (HDL), TC/HDL ratio, non-HDL
(TC-HDL), low-density lipoproteins (LDL), triglycerides
(TRG) and blood glucose (Cholestech LDX Analyzer;
Cholestech Corp, Hayward, CA). Inter-assay coefficient of
variation was 2.1%, 4.0%, 4.2%, 4.1%, 4.7%, and 2.3% for
TC, HDL, non-HDL, LDL, TRG, and glucose, respectively.
Total nitrate/nitrite (NOx) and cortisol were determined
in duplicate and triplicate, respectively, using commercially
available ELISA kits (R&D Systems, Inc., Minneapolis, MN,
USA). High-sensitivity C-reactive protein (hs-CRP) was
determined in triplicate using ELISA (IBL International,
Inc. Hamburg, Germany). The intra-assay coefficient of
variation for NOx, cortisol, and hs-CRP was 3.3%, 11.3%,
and 7.4%, respectively.
Nutrition analysis
Dietary analysis was measured using three-day food (two
weekdays and one weekend day) records before training
Table 1 Resistance training protocol










RT, resistance training. RM, repetition maximum. #, number.
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asked to maintain their normal eating patterns and habits.
FoodWise™ dietary analysis software (McGraw-Hill, New
York, NY) was used for analysis. Participants were asked
to mimic their pre-baseline day of eating prior to post-
testing to the best of their ability based off of their
dietary food logs.
Reported side effects from supplements
Participants were asked at each exercise session about
any supplement side effects. In addition, they were asked
to fill out a questionnaire regarding any side effects at
the end of testing (six weeks).
Supplement analysis
To verify the absence of anabolic steroids, other illicit
substances, and concentration of caffeine, the supplements
and Placebo were sent to a third party laboratory for
analysis (West Chester University of Pennsylvania, West
Chester, PA). The samples submitted for analysis were
mixed thoroughly and test samples weighed out. Each of
these test samples was treated independently and studied
in replicate. The analytes of interest were extracted into
methanol using liquid-liquid extraction and quantitatively
analyzed using gas chromatography–mass spectrometry
(GC-MS). A Varian CP 3800 gas chromatograph- Saturn
2000 mass spectrometer with a Rxi-5Sil MS (30 m × 0.25
mm ID× 0.25 μm) column was used for the analyses.
Standards of caffeine purchased from Cerilliant (Round
Rock, TX) were used to generate instrument mass-response
graphs used for quantitation.
Performance outcomes
Performance data for this study have been reported
previously [18]. Briefly, 1 repetition maximum strength
(1RM) of the chest and legs was determined according to
National Strength and Conditioning Association (NSCA)
1RM guidelines [19], maximal power was determined with
a Wingate test (Monark Ergomedic 874-E, Vansbro,
Sweden), and maximal isokinetic and isometric strength
was determined with a Biodex System 3 Dynamometer
(Shirley, New York).
Resistance training protocol
All participants completed RT three-days per week for
six weeks. The RT protocol was designed to target all of
the major muscle groups (chest, back, trapezius, biceps,
triceps, shoulders, legs, and abdominals) and was modified
from our previous research [4,20] and that of others
[13]. This protocol was chosen to allow for periodized
progression in weight lifted while decreasing repetitions
in order to continually challenge these well-trained athletes.
In addition, we opted to follow a three-day protocol rather
than a four-day protocol in order to provide the propersupervision of all RT sessions while allowing adequate
recovery for the participants. Prior to each exercise
session, participants performed a standardized five-minute
warm-up on a treadmill. For weeks one and two, three
sets of 10 repetitions of each exercise were completed at
70-75% 1RM. For weeks three and four, three sets of six
repetitions of each exercise were completed at 80-85%
1RM. For weeks five and six, three sets of four repetitions
of each exercise were completed at 85-90% 1RM (Table 1).
Day one exercises included flat bench press, incline bench
press, chest fly, latissimus pull down, seated row, and
shrugs. Day two exercises included leg press, step-ups, leg
curl, heel raise, lunge, abdominal crunch, and plank (held
60 seconds). Day three exercises included biceps curl,
alternate curl, overhead triceps extension, triceps press
down, shoulder press, and reverse fly. Rest intervals were
60–90 seconds between sets and 120 seconds between
exercises. If a participant was unable to perform the
prescribed weight for an exercise, the weight was adjusted
to yield failure at or near the specified number of repeti-
tions. The emphasis placed on consistent lifting form in
this study, coupled with researcher supervision from
certified personal trainers through the NSCA, helped
ensure full participant compliance with training as well
as reduce variability due to inter-subject differences or
deficiencies in form.
Statistical analysis
Data were analyzed using a one-way analysis of variance
(ANOVA) to determine if there were differences between
groups in baseline data. A 2 × 2 (group × time) ANOVA
with repeated measures was used to determine the effects
of the supplement and Placebo on the dependent
measures. A Tukey post hoc analysis was used to identify
significant differences when a significant F-ratio was
obtained. Significance is reported at p < 0.05, and all values
are reported as means ± standard deviation (SD). JMP Pro
9 statistical software (SAS Institute Inc., Cary, NC) was
used for all analyses.
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Participant characteristics
Twenty-four participants completed the study. MIPS
(n = 13) had an average age of 23.6 ± 3.5 years, height of
180.6 ± 6.7 cm, and body mass of 83.4 ± 11.5 kg. Placebo
(n = 11) had an average age of 23.6 ± 4.6 years, height of
181.0 ± 4.7 cm, and body mass of 82.2 ± 7.2 kg. Groups
were not different at baseline (Table 2). Participants were
monitored by research personnel with NSCA certifications
for all training and supplement consumption on training
days. As a result, 100% compliance was observed for these
days with respect to both RTand supplement consumption.
On non-training days, participants verbally reported 100%
compliance for supplement ingestion and returned all
empty single-serving supplement containers as evidence.
As previously reported [18], our periodized RT protocol
resulted in significant improvements in 1RM strength in
both MIPS and Placebo participants indicating that the
protocol was effective in increasing strength.
Profile of mood states
No group × time interactions were observed for any profile
of mood state variables (p > 0.05). However, there was a
main effect of time (p = 0.014) by which training resulted
in an increase in vigor regardless of group (MIPS: pre
15.6 ± 5.8, post 18.1 ± 6.9, +16% vs. Placebo: pre 17.3 ± 6.9,
post 20.1 ± 4.7, +16%).
Blood pressure and heart rate
SBP (MIPS: pre 120 ± 10 mmHg, post 117 ± 14 mmHg;
Placebo: pre 116 ± 7 mmHg, post 115 ± 10 mmHg) and
DBP (MIPS: pre 74 ± 10 mmHg, post 72 ± 10 mmHg;
Placebo: pre 69 ± 8, post 67 ± 9 mmHg) were unchanged
as a result of training in both groups. Resting HR also
did not change as a result of training or supplementation
(MIPS: pre 62 ± 8 bpm, post 66 ± 12 bpm; Placebo: pre
59 ± 6 bpm, post 61 ± 11 bpm).
Body composition
Total body mass (Table 3) was increased in both groups
(p < 0.0001) but more so in MIPS than Placebo (p = 0.024).
FFM (Table 3) was increased in both groups (p < 0.0001);Table 2 Participant characteristics at baseline (n = 24)
MIPS Placebo p
n 13 11
Age (years) 23.6 ± 3.5 23.6 ± 4.6 0.958
Training (years) 6.1 ± 3.4 4.5 ± 3.7 0.291
Height (cm) 180.6 ± 6.7 181.0 ± 4.7 0.856
Body Mass (kg) 83.4 ± 11.5 82.2 ± 7.2 0.767
BMI (kg/m2) 25.4 ± 2.2 25.1 ± 2.0 0.664
Data are mean ± SD. MIPS, multi-ingredient performance supplement. Placebo,
carbohydrate placebo. BMI, body mass index.however, the increases were significantly greater with
MIPS (p = 0.025). Total body (p = 0.0005), android
(p = 0.0009), and gynoid (p = 0.002) fat percentages
all significantly decreased over time, with no group by
time differences (Figure 1).
Cardiovascular and metabolic biomarkers
Blood markers of CV and metabolic health (blood lipid
profile, glucose, cortisol, NOx, and hs-CRP) were within
normal clinical ranges for the entirety of this study.
There were no time or group × time (p > 0.05) effects
observed (Table 4) for any of these measures. The sample
sizes differed slightly between biomarkers because some
participants’ samples were not useable or blood was
unable to be drawn.
Nutritional analysis
Data regarding nutritional intake have been reported
previously [18]. Briefly, all participants were asked to
complete a three-day food record before RT and during
the final week of RT, only eight of the participants
(MIPS, n = 5; Placebo, n = 3) returned satisfactory food
records to the research staff for analysis. However, the
participant population included only highly resistance-
trained individuals and thus, they verbally reported
monotonous eating patterns and were instructed to repli-
cate pre-baseline testing nutritional intake for post-testing.
Briefly, total Calories (MIPS, 37.6 ± 8.3 kcal/day/kg vs.
Placebo, 25.3 ± 5.8 kcal/day/kg, p = 0.34), carbohydrate
(MIPS, 3.2 ± 0.7 g/day/kg vs. Placebo, 2.5 ± 0.8 g/day/kg,
p = 0.49), protein (MIPS, 1.9 ±0.5 g/day/kg vs. Placebo,
1.4 ± 0.3 g/day/kg, p = 0.56), and fat intake (MIPS, 1.8 ±
0.8 g/day/kg vs. Placebo, 1.0 ± 0.9 g/day/kg, p = 0.51) for
this subgroup (n = 8) was not different at baseline, remained
unchanged for the duration of the study and was not
different between groups [18].
Performance data
Performance data have been reported previously [18].
Briefly, no differences existed between groups for training
volume and both groups had significant increases in 1RM
strength for upper and lower body with no difference
between groups (Leg press, MIPS: pre 336 ± 24 kg, post
418 ± 25 kg, p < 0.001; Placebo: pre 318 ± 28 kg, post
429 ± 29 kg, p < 0.001; Chest press, MIPS: pre 112 ± 7 kg,
post 123 ± 7 kg, p =0.001; Placebo, pre 118 ± 8 kg, post
127 ± 8 kg, p = 0.001).
Reported side effects
Over the six-week study nausea and dry-mouth was
reported by one participant in MIPS. Feelings of
paresthesia were reported by two participants in MIPS
and two participants in the Placebo group. No other side
effects were reported.
Table 3 Body composition at baseline and after six weeks of supplementation and resistance training (n = 24)
Variable Group Baseline Post Time Group x Time
Body Mass (kg) MIPS 83.4 ± 11.5 85.8 ± 11.8 <.0001* 0.024†
Placebo 82.2 ± 7.2 83.3 ± 7.7
Fat Free Mass (kg) MIPS 66.8 ± 9.2 69.6 ± 9.2 <.0001* 0.025†
Placebo 66.9 ± 5.3 68.2 ± 6.0
Body Fat % MIPS 20.7 ± 4.0 19.5 ± 3.8 0.0005* 0.682
Placebo 20.2 ± 5.0 19.2 ± 4.8
Android Region Fat % MIPS 22.3 ± 7.0 20.5 ± 6.8 0.0009* 0.846
Placebo 20.6 ± 8.7 19.0 ± 8.7
Gynoid Region Fat % MIPS 20.8 ± 4.3 19.5 ± 3.7 0.0019* 0.666
Placebo 21.1 ± 6.1 20.1 ± 5.9
Data are mean ± SD. *Indicates a significant main effect of time. † Indicates a significant difference between groups (p < 0.05). MIPS, multi-ingredient performance
supplement (N = 13). Placebo, carbohydrate placebo (N = 11).
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Caffeine was only present in the pre-workout supplement
(SHOT; 190 mg ± 10 mg per 21 g serving). No additional
stimulants were detected in either supplement. No
quantifiable amounts of caffeine were detected in the
post exercise supplement. These data are in agreement
with the supplement fact sheet listed by the manufacturer.
No other adulterants such as commonly abused stimulants
and known anabolic steroids were detected.
Discussion
The primary findings from this investigation were that six
weeks of MIPS during RT did not alter CV or metabolic
health (blood lipid profile, SBP, DBP, HR, glucose, cortisol,Figure 1 Body composition pre and post six weeks of supplementatio
android fat percent, and D) gynoid fat percent before and after six weeks o
performance supplement (MIPS) or a carbohydrate Placebo pre- and post-exe
testing. *, P < 0.05 compared to baseline. †, P < 0.05 compared to Placebo at tNOx, or hs-CRP) in resistance-trained men. Feelings of
vigor and maximal strength increased in both groups
regardless of MIPS or Placebo. In addition, six weeks of
MIPS in resistance-trained men appear to improve body
composition to a greater degree than Placebo. This is in
agreement with the results of others who have reported
similar findings in untrained participants [12,13]. These
studies also reported an improvement in muscle mass
and body composition in untrained men without any
deleterious effect on blood safety markers when consuming
MIPS either before or before and after RT for four weeks
[12,13]. It has not been determined until now, however,
whether MIPS impact CV (e.g. blood lipids, BP, and HR)
and/or metabolic (e.g. cortisol) health and body compositionn and resistance training. A) fat-free mass, B) total fat mass C)
f resistance training and supplementation with a multi-ingredient
rcise in resistance-trained men. White bars, pre-testing; Dark bars, post-
he same time point.
Table 4 Serum measurements
Variable Group n Baseline Post Time Group x Time
Triglycerides MIPS 10 90.6 ± 27.1 118.5 ± 41.6 0.1124 0.571
mg/dL Placebo 7 89.3 ± 26.9 102.9 ± 47.8
Total Cholesterol MIPS 13 150.4 ± 31.4 145.0 ± 18.6 0.9464 0.273
mg/dL Placebo 9 162.8 ± 47.5 167.6 ± 41.5
HDL MIPS 13 44.5 ± 7.4 42.6 ± 8.2 0.3284 0.978
mg/dL Placebo 11 45.0 ± 13.2 43.1 ± 6.6
LDL MIPS 10 89.5 ± 29.0 82.7 ± 19.4 0.9253 0.201
mg/dL Placebo 7 103.7 ± 29.7 109.5 ± 46.6
Non-HDL MIPS 13 105.9 ± 30.0 101.2 ± 21.1 0.9725 0.249
mg/dL Placebo 9 117.8 ± 47.6 122.2 ± 43.5
Glucose MIPS 12 94.4 ± 4.0 97.1 ± 10.1 0.2655 0.821
mg/dL Placebo 10 92.1 ± 10.4 94.0 ± 6.8
Cortisol MIPS 13 123.4 ± 57.2 123.4 ± 65.8 0.5071 0.503
nmol/L Placebo 11 116.2 ± 37.1 98.4 ± 31.5
Endogenous Nitrite MIPS 13 5.3 ± 1.6 5.2 ± 1.1 0.9663 0.761
(μmol/L) Placebo 11 5.3 ± 1.2 5.4 ± 1.4
Total Nitrite MIPS 13 18.4 ± 18.5 17.9 ± 18.0 0.7688 0.957
(μmol/L) Placebo 11 20.6 ± 20.6 20.2 ± 20.2
Nitrate MIPS 13 13.1 ± 6.5 12.7 ± 11.0 0.7782 0.978
(μmol/L) Placebo 11 15.3 ± 6.5 14.8 ± 9.1
Nitrate/Nitrite MIPS 13 0.5 ± 0.4 0.7 ± 0.7 0.3325 0.629
Placebo 11 0.4 ± 0.2 0.4 ± 0.3
hs-CRP MIPS 11 1.0 ± 0.87 1.1 ± 0.97 0.1478 0.199
(mg/L) Placebo 8 0.78 ± 0.89 2.1 ± 2.7
Data are mean ± SD. HDL, high-density lipoprotein; LDL, low-density lipoprotein; Non-HDL, total cholesterol minus HDL; hs-CRP, high-sensitivity C-reactive protein.
MIPS, multi-ingredient performance supplement. Placebo, carbohydrate placebo. Sample size between each analyte is slightly different due technical difficulties
with certain samples.
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this class of ergogenic aid). For this reason, we sought
to investigate the effects of six weeks of pre- and
post-RT MIPS consumption with periodized RT on CV
and metabolic health and body fat in resistance-trained
men.
Changes in body composition in the current study were
dramatic and in some variables, greater than expected
based on the current literature. We observed an increase
in total body mass in both MIPS (2.9%) and Placebo
(1.3%) with MIPS exhibiting a significantly greater
gain than Placebo (p = 0.02). Participants in MIPS also
increased FFM significantly more than Placebo (+4.2% vs.
+1.9%, respectively, p = 0.025). Similar to Shelmadine et al.
[12], these gains mirror increases in FFM measured in
untrained men after four weeks of RT with a pre-workout
only performance supplement that was the same as was
used in the present study (SHOT, +4.8% vs. placebo, +
1.7%). In addition, Spillane et al. [13] reported similar
findings of increased FFM in untrained men after fourweeks of RT when supplementing both pre- and post-RT
with the identical performance supplements used in the
present study (+3.7%) compared to placebo (+1.0%). It is
surprising that our findings so closely mimic the results
reported in untrained populations despite our participants
averaging 4–7 years of RT experience and substantially
higher baseline FFM (+9-13 kg) than participants in the
aforementioned studies [12,13]. The increase in FFM is
most likely due to the creatine and/or β-alanine in the
product; however, due to the proprietary nature of this
supplement, the exact amounts of these ingredients are
unknown in the product.
Body fat percent decreased significantly in both groups
and this was not solely a function of increased FFM.
Total body fat decreased by 2.6 and 3.5% in MIPS and
Placebo, respectively. In addition, android (MIPS: -1.8;
Placebo: -1.4%) and gynoid fat % (MIPS: -1.3; Placebo: -1.0%)
decreased significantly in both groups. Android fat is
highly associated with increased risk of CV mortality and
diabetes mellitus and thus, it is notable that our RT
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gynoid fat. Our findings are supported by research
demonstrating that exercise can decrease body fat inde-
pendent of supplementation [17,21]. Our prior work has
shown increased lipolysis with just one bout of RT in
resistance-trained men [4] and in overweight/obese
sedentary men [20]. A gain in FFM with concurrent
decreases in body fat is a highly desirable goal of athletes in
many different sports as well as recreational weight-lifters.
Our findings support the supplementation of MIPS in
combination with periodized RT as an effective method of
improving body composition.
Regarding the multitude of individual ingredients in
the proprietary blend of SHOT and SYN, including
whey protein, BCAA’s, creatine, caffeine, β-alanine, and
L-arginine, it is difficult to isolate their specific effects.
In fact, some research suggests a synergistic effect of
ingredients in the investigated supplements [22-24].
The increases in FFM we observed may likely be explained
by studies that used supplementation of creatine with
β-alanine [22] or whey protein and amino acids [23].
Hoffman et al. [22] demonstrated that RT in combination
with supplementation of creatine and β-alanine decreased
body fat by 1.2% through an increase in lean body mass
(LBM) (1.74 ± 1.72 kg) greater than creatine alone (data
not reported) or a carbohydrate placebo (0.44 ± 1.62 kg) in
collegiate football players. Willoughby et al. [23] observed
an increase in FFM of 5.6% when combining 14 g of
whey and casein protein with 6 g of free amino acids as
compared to a 2.7% increase with a carbohydrate placebo
supplement in untrained men following 10 weeks of heavy
RT (3 sets of 6–8 reps with 85-90% 1RM, 4×/wk). Perhaps
most relevant to the present study, Schmitz et al. [24]
recorded 2.4% and 0.27% (p = 0.049) increases in LBM
in trained participants (≥ two years RT experience)
supplementing with MIPS with and without BCAA’s,
respectively. The investigators implemented a nine-week
progressive overload RT regimen with participants training
four times a week. The two supplements were matched
for creatine (4 g), protein (7 g), and carbohydrate (39 g).
The supplements from the present study include the
primary ingredients from these studies [22-24] and
alternative ingredients in a proprietary blend that are
purported to improve body composition. Our results
suggest that the ingredients in SHOT and SYN may be
working together to improve body composition greater
than the Placebo.
All measured CV and metabolic variables were within
normal clinical ranges at baseline and post-six weeks in
the present study. Interventions using various intensities
of RT with untrained participants have significantly lowered
LDL cholesterol in the same six-week span as the present
study [25]. While RT may also improve TRG in untrained
individuals [26], our participants were experienced withRT, which likely contributed to the lack of difference
measured in these variables. Our findings are supported
by previous studies in untrained men [12,13] using
SHOT and SYN, which also report no changes in CV
health variables after 4 weeks of RT in men of similar
age to participants in the current study.
Cortisol is widely accepted as both a catabolic biomarker
and an indicator of overall stress. Based on the current
literature, we hypothesized a decrease in cortisol concen-
tration in MIPS but measured no changes. Bird et al. [27]
reported that both carbohydrate (6%) and carbohydrate
(6%) with essential amino acid supplementation (6 g) during
an acute bout of RT suppressed the cortisol response in
untrained men compared to a placebo. This may have
been due to a glucoregulatory effect in which carbohydrate
was an adequate source of energy to prevent the need for
cortisol to stimulate the liver to release glucose. Sharp and
Pearson [28] demonstrated decreased cortisol concentra-
tions in recreationally active young men after three weeks
of BCAA supplementation (6 g/day) followed by a fourth
week of supplementation and four bouts of RT (three
sets of 6–8 repetitions with 80% 1RM and 60 seconds
between sets and exercises, three lower- and five- upper
body exercises). The authors reported significant decreases
in cortisol 12 hrs after RT bout two, and 12 and 36 hrs
after RT bout four. Because of the low-training status of the
participants, the RT was deemed an over-reaching training
week. Two factors that may have contributed to the differ-
ences observed in our data are the experienced training sta-
tus of our participants and the slightly later (36 vs. 48 hrs)
post-training cortisol measurements in the present study.
Our data indicate training-status may be a determining
factor in resting cortisol concentrations with performance
nutrition supplementation.
Total nitrate/nitrite (NOx), which is indicative of
production of the potent vasodilator, nitric oxide, was
also measured to evaluate the impact on CV health. Nitric
oxide is synthesized from L-arginine and L-citrulline, two
amino acids present in the MIPS in the present study.
Nitric oxide has been reported to improve CV health
through vasodilation and prevention of lipid build-up on
the arterial walls [29]; however, this finding is specific to
diseased populations [30]. We recorded no change in
resting NOx within or between groups during the interven-
tion, which agrees with most previously published research
[13] in healthy individuals. Interestingly, L-arginine has
recently been shown to increase blood volume within
the muscle (measured with near-infrared spectroscopy)
without changing NOx [31]. It is possible that our partici-
pants experienced similar changes in blood volume without
the detection of any change in NOx. In addition, by design,
we sampled blood 48 hrs following the last training bout
to measure the impact of supplementation and training
over time rather than acute response to RT.
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reflect total body inflammation. Clinical data indicate
values of <1, 1–3, >3 mg/L as low, moderate, and high risk,
respectively, for CV disease. We recorded no significant
changes in hs-CRP within or between groups. Kadaglou
et al. [32] recently reported no change in CRP following
three months of RT (3×/week) in type two diabetic
patients. Conversely, Sheikholeslami et al. [25] demonstrated
significantly lower CRP values in untrained men fol-
lowing six weeks of moderate (45-55% 1RM) or high
intensity (80-90% 1RM) RT in healthy males compared
to a non-intervention control group. The discrepancy
in results may be due to the experienced training
status of our participants compared to diabetic and
untrained individuals. In addition, CRP is notorious
for its high intra-subject variability [33] and may have
confounded our results.
While RT may independently improve BP in untrained
normotensive and pre-hypertensive individuals [26], our
data did not indicate changes in BP, perhaps due to our
participants’ RT history. Similarly, we saw no changes in
HR, likely due to their training status. Research indicates
that caffeine, a central ingredient in SHOT, the pre-exercise
MIPS used in the present study, can increase HR, SBP,
and DBP acutely [9]. Energy drinks with less caffeine than
SHOT (80 vs ~190 mg, respectively) have been reported
to elevate BP up to 24 hrs after consumption in nine
healthy (aged 18–45 years), nonsmoking, normotensive
men (n = 4) and women (n = 5) who self-reported to
consume between four and 379 mg/day of caffeine (four
participants reported habitual caffeine intake) [34].
However, some research suggests chronic coffee drinkers
are at a decreased risk for developing CV disease [35]. No
published research indicates the HR and BP response to
caffeine-containing MIPS.
Regarding mood states, RT elicited an increase in
vigor for both MIPS and Placebo. This indicates that it
was unlikely our participants were overtrained at the
post-testing time point. Bresciani et al. [36] reported a
non-significant decrease in vigor and a significant
decrease in total mood as being indicative of overtraining
in active men.
Resistance-trained men appear to tolerate SHOT and
SYN better than their untrained counterparts. Indeed,
Shelmadine et al. [12] reported feelings of dizziness,
nausea, headache, rapid HR, shortness of breath, and
nervousness after consuming SHOT in untrained men.
Similarly, Spillane et al. [13] reported select untrained
participants experiencing the same side-effects while
supplementing with both SHOT and SYN. Only one
individual taking SHOT and SYN in the present study
reported feeling nauseous while two others reported
feelings of paresthesia (although two people in Placebo
also reported feeling paresthesia). It is probable thatindividuals experienced in RT are also experienced with
a variety of MIPS and may be more tolerant or less likely
to report side effects if any were present.Limitations
The present study was limited by the accuracy of
self-reported dietary intake and supplement consumption
on non-training days. However, our research staff collected
empty supplement single-serving Ziploc® bags three
times per week in an effort to verify compliance and all
participants verbally reported no change in eating patterns.
Due to the small sample of useable nutrition logs, it is
possible that we did not have a representative sample to
determine no differences between groups. However, all
participants were questioned personally and reported no
change in dietary habits for the duration of the six-week
study. In addition, differences in prior training status of
our participants may have limited our findings; however,
even though MIPS had a longer training history (Table 2),
they still were able to increase FFM more than Placebo. In
addition, those in the MIPS group may have been able to
recognize the feelings from the pre-workout supplement
that contained caffeine and β-alanine and known they
were in the supplement group. Moreover, participants
were not monitored 24 hours per day and thus may have
been able to discuss how the supplement felt to them.
However, all training was completed with limited contact
to other participants and any interaction would have been
outside of workout and/or laboratory visits. Lastly, we do
not have reliability data for the POMS assessment used in
this study.Conclusions
Considering the popularity of MIPS, it is important to
confirm their safety and efficacy. Six weeks of MIPS
before and after RT does not alter HR, SBP, DBP, fasted
blood lipids, glucose, cortisol, NOx, or hs-CRP in healthy
resistance-trained men. However, FFM was increased to a
greater extent in MIPS than Placebo and improvements
occurred in regional body fat and feelings of vigor, regard-
less of treatment group. Future studies investigating the
effects of MIPS on cardiometabolic health variables and
body composition should consider closely controlling
diet, extending supplementation beyond six weeks, and
including female participants and individuals older than
40 years of age.Competing interests
This study was supported by an independent research grant and
product donation from VPX Pharmaceuticals (Davie, FL). None of the
authors had financial or other interests concerning the outcomes of
the investigation. The authors declare that they have no competing
interests.
Ormsbee et al. Nutrition & Metabolism 2013, 10:39 Page 10 of 11
http://www.nutritionandmetabolism.com/content/10/1/39Authors’ contributions
MJO conceived and designed the study, secured funding for the project,
provided oversight of data collection, analysis, biochemical assays, and
manuscript preparation. DDT carried out all subject recruitment, data
collection, exercise training, immunoassays, and assisted with manuscript
preparation. WKM carried out data collection, participant recruitment, and
exercise training. AWK, EGW, SH, and ES helped with data collection and
analysis. LBP, TPS, and JSK provided assay support, and insight into drafting
the study design and manuscript. All authors read and approved the final
manuscript.
Acknowledgements
The authors would like to thank the participants and our personal training
staff for their dedication and participation in this study. We would like to
thank Jim and Joe Burtoft for generously allowing us to use their Gold’s Gym
facilities in Tallahassee, FL. We would also like to thank C. Riley, M. Joshi, S.
Little, and J. Washburn for analytical support.
Author details
1Dept. of Nutrition, Food and Exercise Sciences, The Florida State University,
120 Convocation Way, 430 Sandels Building, Tallahassee, FL 32306, USA.
2Dept. of Health and Human Performance, College of Charleston, 66 George
St, Charleston, SC 29424, USA. 3School of Exercise & Nutritional Sciences, San
Diego State University, San Diego, CA 92182, USA. 4Dept. of Kinesiology,
Georgia College and State University, Milledgeville, GA 31061, USA.
Received: 6 February 2013 Accepted: 25 April 2013
Published: 16 May 2013
References
1. Young CR, Stephens MB: Sports and nutritional supplement use in USMC
recruits: a pilot study. Mil Med 2009, 174:158–161.
2. Maughan RJ, Depiesse F, Geyer H: International Association of Athletics
Federations: The use of dietary supplements by athletes. J Sports Sci
2007, 25(Suppl 1):S103–13.
3. Kosek DJ, Kim JS, Petrella JK, Cross JM, Bamman MM: Efficacy of 3 days/wk
resistance training on myofiber hypertrophy and myogenic mechanisms
in young vs. older adults. J Appl Physiol 2006, 101:531–544.
4. Ormsbee MJ, Thyfault JP, Johnson EA, Kraus RM, Choi MD, Hickner RC: Fat
metabolism and acute resistance exercise in trained men. J Appl Physiol
2007, 102:1767–1772.
5. Cribb PJ, Williams AD, Carey MF, Hayes A: The effect of whey isolate and
resistance training on strength, body composition, and plasma
glutamine. Int J Sport Nutr Exerc Metab 2006, 16:494–509.
6. Cramer JT, Stout JR, Culbertson JY, Egan AD: Effects of creatine
supplementation and three days of resistance training on muscle
strength, power output, and neuromuscular function. J Strength Cond Res
2007, 21:668–677.
7. Green JM, Wickwire PJ, McLester JR, Gendle S, Hudson G, Pritchett RC,
Laurent CM: Effects of caffeine on repetitions to failure and ratings of
perceived exertion during resistance training. Int J Sports Physiol Perform
2007, 2:250–259.
8. Kendrick IP, Harris RC, Kim HJ, Kim CK, Dang VH, Lam TQ, Bui TT, Smith M, Wise
JA: The effects of 10 weeks of resistance training combined with beta-alanine
supplementation on whole body strength, force production, muscular
endurance and body composition. Amino Acids 2008, 34:547–554.
9. Karatzis E, Papaioannou TG, Aznaouridis K, Karatzi K, Stamatelopoulos K,
Zampelas A, Papamichael C, Lekakis J, Mavrikakis M: Acute effects of caffeine
on blood pressure and wave reflections in healthy subjects: should we
consider monitoring central blood pressure? Int J Cardiol 2005, 98:425–430.
10. Vlachopoulos C, Panagiotakos D, Ioakeimidis N, Dima I, Stefanadis C:
Chronic coffee consumption has a detrimental effect on aortic stiffness
and wave reflections. Am J Clin Nutr 2005, 81:1307–1312.
11. Astorino TA, Rohmann RL, Firth K, Kelly S: Caffeine-induced changes in
cardiovascular function during resistance training. Int J Sport Nutr Exerc
Metab 2007, 17:468–477.
12. Shelmadine B, Cooke M, Buford T, Hudson G, Redd L, Leutholtz B, Willoughby
DS: Effects of 28 days of resistance exercise and consuming a commercially
available pre-workout supplement, NO-Shotgun(R), on body composition,
muscle strength and mass, markers of satellite cell activation, and clinical
safety markers in males. J Int Soc Sports Nutr 2009, 6:16.13. Spillane M, Schwarz N, Leddy S, Correa T, Minter M, Longoria V, Willoughby
DS: Effects of 28 days of resistance exercise while consuming
commercially available pre- and post-workout supplements, NO-Shotgun
and NO-Synthesize on body composition, muscle strength and mass,
markers of protein synthesis, and clinical safety markers in males.
Nutr Metab (Lond) 2011, 8:78.
14. Smith AE, Fukuda DH, Kendall KL, Stout JR: The effects of a pre-workout
supplement containing caffeine, creatine, and amino acids during three
weeks of high-intensity exercise on aerobic and anaerobic performance.
J Int Soc Sports Nutr 2010, 7:10.
15. McKenna MJ, Morton J, Selig SE, Snow RJ: Creatine supplementation
increases muscle total creatine but not maximal intermittent exercise
performance. J Appl Physiol 1999, 87:2244–2252.
16. McNair DM, Lorr M, Droppleman LF: Manual for the profile of mood states.
San Diego, CA: Educational and Industrial Testing Services; 1971.
17. Arciero PJ, Gentile CL, Martin-Pressman R, Ormsbee MJ, Everett M, Zwicky L,
Steele CA: Increased dietary protein and combined high intensity aerobic
and resistance exercise improves body fat distribution and
cardiovascular risk factors. Int J Sport Nutr Exerc Metab 2006, 16:373–392.
18. Arciero PJ, Gentile CL, Pressman R, Everett M, Ormsbee MJ, Martin J,
Santamore J, Gorman L, Fehling PC, Vukovich MD, Nindl BC: Moderate
protein intake improves total and regional body composition and insulin
sensitivity in overweight adults. Metab Clin Exp 2008, 57:757–765.
19. Hoffman J, Ratamess N, Kang J, Mangine G, Faigenbaum A, Stout J: Effect
of creatine and beta-alanine supplementation on performance and
endocrine responses in strength/power athletes. Int J Sport Nutr Exerc
Metab 2006, 16:430–446.
20. Ormsbee MJ, Choi MD, Medlin JK, Geyer GH, Trantham LH, Dubis GS,
Hickner RC: Regulation of fat metabolism during resistance exercise in
sedentary lean and obese men. J Appl Physiol 2009, 106:1529–1537.
21. Ormsbee MJ, Mandler WK, Thomas DD, Ward EG, Kinsey AW, Simonavice E,
Panton LB, Kim JS: The effects of six weeks of supplementation with
multi-ingredient performance supplements and resistance training on
anabolic hormones, body composition, strength, and power in
resistance-trained men. J Int Soc Sports Nutr 2012, 9:49.
22. Willoughby DS, Stout JR, Wilborn CD: Effects of resistance training and
protein plus amino acid supplementation on muscle anabolism, mass,
and strength. Amino Acids 2007, 32:467–477.
23. Schmitz SM, Hofheins JE, Lemieux R: Nine weeks of supplementation with
a multi-nutrient product augments gains in lean mass, strength, and
muscular performance in resistance trained men. J Int Soc Sports Nutr
2010, 7:40.
24. Sheikholeslami Vatani D, Ahmadi S, Ahmadi Dehrashid K, Gharibi F:
Changes in cardiovascular risk factors and inflammatory markers of
young, healthy, men after six weeks of moderate or high intensity
resistance training. J Sports Med Phys Fitness 2011, 51:695–700.
25. Cornelissen VA, Fagard RH, Coeckelberghs E, Vanhees L: Impact of
resistance training on blood pressure and other cardiovascular risk
factors: a meta-analysis of randomized, controlled trials.
Hypertension 2011, 58:950–958.
26. Bird SP, Tarpenning KM, Marino FE: Effects of liquid carbohydrate/essential
amino acid ingestion on acute hormonal response during a single bout
of resistance exercise in untrained men. Nutrition 2006, 22:367–375.
27. Sharp CP, Pearson DR: Amino acid supplements and recovery from
high-intensity resistance training. J Strength Cond Res 2010, 24:1125–1130.
28. Gkaliagkousi E, Ferro A: Nitric oxide signalling in the regulation of
cardiovascular and platelet function. Front Biosci 2011, 16:1873–1897.
29. Orea-Tejeda A, Orozco-Gutierrez JJ, Castillo-Martinez L, Keirns-Davies C,
Montano-Hernandez P, Vazquez-Diaz O, Valdespino-Trejo A, Infante O,
Martinez-Memije R: The effect of L-arginine and citrulline on endothelial
function in patients in heart failure with preserved ejection fraction.
Cardiol J 2010, 17:464–470.
30. Franks AM, Schmidt JM, McCain KR, Fraer M: Comparison of the effects of
energy drink versus caffeine supplementation on indices of 24-hour
ambulatory blood pressure. Ann Pharmacother 2012, 46:192–199.
31. Alvares TS, Conte CA, Paschoalin VM, Silva JT, Meirelles Cde M, Bhambhani YN,
Gomes PS: Acute l-arginine supplementation increases muscle blood volume
but not strength performance. Appl Physiol Nutr Metab 2012, 37:115–126.
32. Kadoglou NP, Fotiadis G, Athanasiadou Z, Vitta I, Lampropoulos S, Vrabas IS: The
effects of resistance training on ApoB/ApoA-I ratio, Lp(a) and inflammatory
markers in patients with type 2 diabetes. Endocrine 2012, 42:561–569.
Ormsbee et al. Nutrition & Metabolism 2013, 10:39 Page 11 of 11
http://www.nutritionandmetabolism.com/content/10/1/3933. McCormack JP, Allan GM: Measuring hsCRP–an important part of a
comprehensive risk profile or a clinically redundant practice?
PLoS Med 2010, 7:e1000196.
34. Freedman ND, Park Y, Abnet CC, Hollenbeck AR, Sinha R: Association of
coffee drinking with total and cause-specific mortality. N Engl J Med 2012,
366:1891–1904.
35. Bresciani G, Cuevas MJ, Molinero O, Almar M, Suay F, Salvador A, de Paz JA,
Marquez S, Gonzalez-Gallego J: Signs of overload after an intensified
training. Int J Sports Med 2011, 32:338–343.
36. Baechle TR ER: Essentials of strength and conditioning. 3rd edition.
Human Kinetics; 2008.
doi:10.1186/1743-7075-10-39
Cite this article as: Ormsbee et al.: The effects of pre- and post-exercise
consumption of multi-ingredient performance supplements on
cardiovascular health and body fat in trained men after six weeks of
resistance training: a stratified, randomized, double-blind study. Nutrition &
Metabolism 2013 10:39.Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
